Skip to main content
OpenTrials

Clinical trial condition

Hypothalamic Diseases

Explore clinical trials studying Hypothalamic Diseases. Study availability and eligibility vary by location and protocol.

589 public trials 88 recruiting studies
Refine in advanced search Browse all conditions

Hypothalamic Diseases trial results

Completed

An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.

NCT01582061

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +15 more
Locations
  • Advanced Research, LLC Peoria, Arizona, United States
  • St Josephs Hospital & Medical Center St Joes Phoenix, Arizona, United States
  • University of California at Los Angeles UCLA Tiverton Los Angeles, California, United States
  • LA Biomedical Research at Harbor UCLA Medical Center Torrance, California, United States
View all 65 locations
View Trial Details
Completed

Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease

NCT01374906

Conditions
Brain Diseases, Central Nervous System Diseases, Cushing's Disease, +6 more
Locations
  • ClinTriCo Phoenix, Arizona, United States
  • University of California at Los Angeles UCLA Tiverton Los Angeles, California, United States
  • Harbor-UCLA Medical Center LA Biomed Torrance, California, United States
  • Emory University School of Medicine/Winship Cancer Institute G2304 - C2301 Atlanta, Georgia, United States
View all 82 locations
View Trial Details
Completed

Effects of Growth Hormone Supplementation to Adults With Growth Hormone Deficient on Metabolism and Adipose Tissue Molecular Phenotype

NCT01616095

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +11 more
Locations
  • V th Internal Clinic, Univeristy Hospital Bratislava, Comenius University Bratislava, Slovakia
  • Inst. Exp. Endocrinology Slovak Acad Sci Bratislava, Slovakia
  • National Institute of Endocrinology and Diabetology Ľubochňa, Slovakia
View Trial Details
Completed

Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency

NCT02558829

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +11 more
Locations
  • Harbor UCLA Medical Center Torrance, California, United States
  • Texas Diabetes and Endocrinology Austin, Texas, United States
  • Baylor College of Medicine-Endocrinology Houston, Texas, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
View all 27 locations
View Trial Details
Completed

Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly

NCT01137682

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +17 more
Locations
  • University of Michigan Ann Arbor, Michigan, United States
  • Oregon Health & Science University Portland, Oregon, United States
  • University of Texas Southwestern Medical Center Division of Hematology/Oncolog Dallas, Texas, United States
  • Swedish Neuroscience Institute 550 17th Avenue, Suite 500 Seattle, Washington, United States
View all 60 locations
View Trial Details

Related conditions